Goldman Sachs has downgraded its rating for Novo Nordisk from “buy” to “neutral” following disappointing phase 3 clinical trial results for the company’s next-generation obesity medicine,...
A recent study has established a troubling connection between diabetes and an elevated risk of sudden death. According to findings published in the Canadian Medical Association...
Recent data from Statistics Canada reveals a concerning health trend among Canadian adults: approximately two-thirds are classified as overweight or obese. This statistic underscores a growing...
Understanding the impact of statins on heart disease risk has become a critical topic among health care professionals and patients alike. Recent findings emphasize that the...
